Green tea catechins: Biologic properties, proposed mechanisms of action, and clinical implications

Journal of Drugs in Dermatology

Volumn 11, Issue 11, 2012, Pages

  Rosen, Ted ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIVIRUS AGENT; CATECHIN; DICLOFENAC; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; IMMUNOSTIMULATING AGENT;

ACTINIC KERATOSIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; APPLICATION SITE BURNING; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; APPLICATION SITE ULCER; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONDYLOMA ACUMINATUM; CYTOTOXICITY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; EROSION; GROWTH INHIBITION; HUMAN; IMMUNOSTIMULATION; NONHUMAN; OINTMENT; PAPILLOMAVIRUS INFECTION; SKIN INDURATION; TEA; VESICULAR RASH; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIVIRAL AGENTS; CATECHIN; CELL PROLIFERATION; CONDYLOMATA ACUMINATA; HUMANS; PAPILLOMAVIRUS INFECTIONS; PLANT EXTRACTS; PLANT LEAVES; TEA;

EID: 84870202494     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Schmidt B, Ribnicky DM, Poulev A, Logendra S, Cefalu WT, Raskin I. A natural history of botanical therapeutics. Metabolism. 2008;57 Suppl 1:S3-S9. (Pubitemid 351814695)
2. Craker LE, Gardner ZE. Medicinal plants and tomorrow's pharmacy. In: Bogers RJ, Craker LE, Lange D, eds. Medicinal and Aromatic Plants. Netherlands: Springer. 2006:29-41.
3. Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science. 2009;325(5937):161-165.
4. Bent S. Herbal medicine in the United States: review of efficacy, safety, and regulation: grand rounds at University of California, San Francisco Medical Center. J Gen Intern Med. 2008;23(6):854-859.
5. Calixto JB. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res. 2000;33(2):179-189. (Pubitemid 30141010)
6. Rosenbloom RA, Chaudhary J, Castro-Eschenbach D. Traditional botanical medicine: an introduction. Am J Ther. 2011;18(2):158-161.
7. Guidance for Industry: Botanical Drug Products. Center for Drug Evaluation and Research (CDER), Food and Drug Administration. Chemistry. June 2004. Available at: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatory-Information/Guidances/ucm070491.pdf. Accessed September 14, 2012.
8. Akerele O. Nature's medicinal bounty: don't throw it away. World Health Forum. 1993;14(4):390-395. (Pubitemid 24010342)
9. Coates PM, Meyers CM. The National Institutes of Health investment in research on botanicals. Fitoterapia. 2011;82(1):11-13.
10. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci. 2006;78(18):2073-2080.
11. Brown MD. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Altern Med Rev. 1999;4(5):360-370. (Pubitemid 29526341)
12. Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea - a review. J Am Coll Nutr. 2006;25(2):79-99. (Pubitemid 46939847)
13. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43(1):89-143. (Pubitemid 38552312)
14. Vuong QV, Golding JB, Nguyen M, Roach PD. Extraction and isolation of catechins from tea. J Sep Sci. 2010;33(21):3415-3428.
15. Morré DJ, Morré DM, Sun H, Cooper R, Chang J, Janle EM. Tea catechin synergies in inhibition of cancer cell proliferation and of a cancer specific cell surface oxidase (ECTO-NOX). Pharmacol Toxicol. 2003;92(5):234-241. (Pubitemid 36513219)
16. Meltzer SM, Monk BJ, Tewari KS. Green tea catechins for treatment of external genital warts. Am J Obstet Gynecol. 2009;200(3):233.e1-7.
17. Ahn WS, Yoo J, Huh SW, et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev. 2003;12(5):383-390. (Pubitemid 37338812)
18. Mayeaux EJ Jr, Dunton C. Modern management of external genital warts. J Low Genit Tract Dis. 2008;12(3):185-192.
19. Chang LK, Wei TT, Chiu YF, et al. Inhibition of Epstein-Barr virus lytic cycle by (-)-epigallocatechin gallate. Biochem Biophys Res Commun. 2003;301(4):1062-1068.
20. Mukoyama A, Ushijima H, Nishimura S, et al. Inhibition of rotavirus and enterovirus infections by tea extracts. Jap J Med Sci Biol. 1991;44(4):181-186.
21. Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res. 2003;58(2):167-173. (Pubitemid 36556219)
22. Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 2002;53(1):19-34. (Pubitemid 33001552)
23. Fassina G, Buffa A, Benelli R, Varnier OE, Noonan DM, Albini A. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti- HIV agent. AIDS. 2002;16(6):939-941. (Pubitemid 34409024)
24. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 1993;21(4):289-299. (Pubitemid 23231550)
25. Song JM, Lee KH, Seong BL. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 2005;68(2):66-74.
26. Imanishi N, Tuji Y, Katada Y, et al. Additional inhibitory effect of tea extract on the growth of influenza A and B viruses in MDCK cells. Microbiol Immunol. 2002;46(7):491-494. (Pubitemid 34831213)
27. Tyring SK. Sinecatechins: Effects on HPV-induced enzymes involved in inflammatory mediator generation. J Clin Aesthet Dermatol. 2012;5(1):19-26.
28. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res. 1988;48(13):3780-3786.
29. Kang HT, Lee CJ, Seo EJ, Bahn YJ, Kim HJ, Hwang ES. Transition to an irreversible state of senescence in HeLa cells arrested by repression of HPV E6 and E7 genes. Mech Ageing Dev. 2004;125(1):31-40. (Pubitemid 38054349)
30. Rösl F, Das BC, Lengert M, Geletneky K, zur Hausen H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol. 1997;71(1):362-370. (Pubitemid 26412300)
31. Barthelman M, Bair WB 3rd, Stickland KK, et al. (-)-Epigallocatechin- 3-gallate inhibition of ultraviolet B-induced AP-1 activity. Carcinogenesis. 1998;19(12):2201-2204. (Pubitemid 29010263)
32. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer. 2005;113(6):951-960. (Pubitemid 40096875)
33. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene. 2003;22(31):4851-4859. (Pubitemid 36981273)
34. Khafif A, Schantz SP, al-Rawi M, Edelstein D, Sacks PG. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck. 1998;20(6):528-534. (Pubitemid 28361458)
35. Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res. 2001;7(12):4220-4229. (Pubitemid 34044648)
36. Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol. 2004;24(3):703-710.
37. Yokoyama M, Noguchi M, Nakao Y, Pater A, Iwasaka T. The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines. Gynecol Oncol. 2004;92(1):197-204. (Pubitemid 38147391)
38. Naasani I, Oh-Hashi F, Oh-Hara T, et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo. Cancer Res. 2003;63(4):824-830. (Pubitemid 36231983)
39. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3- gallate. J Cell Biochem. 1999;75(1):1-12.
40. Masuda M, Suzui M, Lim JTE, Deguchi A, Soh JW, Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol. 2002;2(6):350-359. (Pubitemid 35265984)
41. Shimizu M, Shirakami Y, Moriwaki H. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG. Int J Mol Sci. 2008;9(6):1034-1049. (Pubitemid 351948839)
42. Sachinidis A, Skach RA, Seul C, et al. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J. 2002;16(8):893-895.
43. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3- gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem. 2004;279(13):12755-12762. (Pubitemid 38445847)
44. Shimizu M, Adachi S, Masuda M, Kozawa O, Moriwaki H. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases. Mol Nutr Food Res. 2011;55(6):832-843.
45. Tyring SK. Effect of sinecatechins on HPV-activated cell growth and induction of apoptosis. J Clin Aesthet Dermatol. 2012;5(2)34-41.
46. Kürbitz C, Heise D, Redmer T, et al. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti-inflammatory activities in pancreatic tumor cells. Cancer Sci. 2011;102(4):728-734.
47. Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol. 2000;164(1):82-90. (Pubitemid 30198547)
48. Ahn WS, Huh SW, Bae SM, et al. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression. DNA Cell Biol. 2003;22(3):217-224. (Pubitemid 36578095)
49. Huh SW, Bae SM, Kim YW, et al. Anticancer effects of (-)- epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol. 2004;94(3):760-768. (Pubitemid 39194472)
50. Inaba H, Nagaoka Y, Kushima Y, et al. Comparative examination of anti-proliferative activities of (-)-epigallocatechin gallate and (-)-epigallocatechin against HCT116 colorectal carcinoma cells. Biol Pharm Bull. 2008;31(1):79-84.
51. Sukhthankar M, Choi CK, English A, Kim JS, Baek SJ. A potential proliferative gene, NUDT6, is down-regulated by green tea catechins at the posttranscriptional level. J Nutr Biochem. 2010;21(2):98-106.
52. Islam S, Islam N, Kermode T, et al. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun. 2000;270(3):793-797. (Pubitemid 30444785)
53. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis. Oncogene. 2004;23(14):2507-2522. (Pubitemid 38520748)
54. Sakagami H, Takeda M, Sugaya K, et al. Stimulation by epigallocatechin gallate of interleukin-1 production by human peripheral blood mononuclear cells. Anticancer Res. 1995;15(3):971-974.
55. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins. Infect Immun. 2001;69(6):3947-3953. (Pubitemid 32493317)
56. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Epigallocatechin gallate, a potential immunomodulatory agent of tea components, diminishes cigarette smoke condensate-induced suppression of anti-legionella pneumophila activity and cytokine responses of alveolar macrophages. Clin Diagn Lab Immunol. 2002;9(4):864-871. (Pubitemid 34773892)
57. Katiyar SK, Challa A, McCormick TS, Cooper KD, Mukhtar H. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis. 1999;20(11):2117-2124.
58. Katiyar SK, Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3- gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol. 2001;69(5):719-726. (Pubitemid 32466409)
59. Elmets CA, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. 2001;44(3):425-432. (Pubitemid 32199961)
60. Yang L, Yamagata N, Yadav R, et al. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J Clin Invest. 2003;111(5):727-735. (Pubitemid 36278591)
61. Jung YD, Kim MS, Shin BA, et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer. 2001;84(6):844-850. (Pubitemid 32275661)
62. Kondo T, Ohta T, Igura K, Hara Y, Kaji K. Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett. 2002;180(2):139-144. (Pubitemid 34327366)
63. Tang FY, Nguyen N, Meydani M. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer. 2003;106(6):871-878. (Pubitemid 37071665)
64. Leong H, Mathur PS, Greene GL. Green tea catechins inhibit angiogenesis through suppression of STAT3 activation. Breast Cancer Res Treat. 2009;117(3):505-515.
65. National Cancer Institute. U.S. Department of Health and Human Services. National Institutes of Health. Human papillomaviruses and cancer. Fact sheet. December 13, 2010:1-4.
66. Cox JT. Epidemiology and natural history of HPV. J Fam Pract. 2006;55 Suppl:3-9. (Pubitemid 44737192)
67. Yang CS, Yang GY, Landau JM, Kim S. Liao J. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp Lung Res. 1998;24(4):629-639. (Pubitemid 28308956)
68. Yang CS, Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res. 2011;55(6):819-831.
69. Veregen [package insert]. Melville, NY: PharmaDerm, A Division of Nycomed US Inc.; April 2011.
70. Tzellos TG, Sardeli C, Lallas A, Papazisis G, Chourdakis M, Kouvelas D. Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2011;25(3):345-353.
71. Stockfleth E, Beti H, Orasan R, et al. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Br J Dermatol. 2008;158(6):1329-1338. (Pubitemid 351692865)
72. Tatti S, Swinehart JM, Thielert C, Tawfik H, Mescheder A, Beutner KR. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Obstet Gynecol. 2008;111(6):1371-1379.
73. Tatti S, Stockfleth E, Beutner KR, et al. Polyphenon E: a new treatment for external anogenital warts. Br J Dermatol. 2010;162(1):176-184.